Login
Explore
- Maps
- Lists
- Tags
About
- LittleSis
- Sign Up
- Help
- API
- Disclaimer
- Contact Us
- Donate
- Newsletter
Features
- Blog
- Toolkit
- Powerlines

Login
Explore
- Maps
- Lists
- Tags
About
- LittleSis
- Sign Up
- Help
- API
- Disclaimer
- Contact Us
- Donate
- Newsletter
Features
- Blog
- Toolkit
- Powerlines

donate

This year LittleSis turned 15! Consider becoming a LittleSustainer to help unsure that our movements have the research and tools
we need to win for the long haul. Any amount is greatly appreciated. Donate today.

Phil Febbo

Chief Medical Officer, Illumina

Febbo is in his present position since 2018, responsible for Illumina's medical strategy to drive genomic testing into healthcare practice. Previously, he was CMO of Genomic Health and professor of medicine and urology at the University of California, San Francisco, where his laboratory focused on using genomics to understand the biology and clinical behavior of prostate cancer. He currently serves on the board of the American College of Medical Genetics and Genomics Foundation.

Relationships Interlocks Giving Data

Business Positions

Illumina, Inc. Develops tools for the research of genetics. Revenues are $3 billion.

• Chief medical officer

Board Memberships

Varian Medical Systems Manufactures radiotherapy systems. Revenues are $3 billion.

• Board Member ('19→?)

Positions

UCSF School of Medicine

• Professor of Medicine and Urology (past)

Updated over 4 years ago

Types	Person, Business Person
Gender	Male